Connecticut CannaTimesFacts first. You decide.
OpinionRegulators

Inside the Retaliation Scandal at Connecticut's DCP

The scandal now engulfing Connecticut’s Department of Consumer Protection (DCP) is not an isolated mistake. It is the inevitable result of a toxic regulatory culture where power is abused, dissent is punished, and the cannabis industry is treated not as a partner but as an enemy.

By Connecticut CannaTimesPublished

Opinion. This piece expresses the view of the publication. It is labeled so readers can distinguish it from news reporting.

In this storyAffinity GrowDCP

By CT CannaTimes Editorial Board

The scandal now engulfing Connecticut’s Department of Consumer Protection (DCP) is not an isolated mistake. It is the inevitable result of a toxic regulatory culture where power is abused, dissent is punished, and the cannabis industry is treated not as a partner but as an enemy.

At the center of this storm is Rodrick Marriott, former Director of DCP’s Drug Control Division. A newly released labor investigation confirms what many in the cannabis community have long suspected: Marriott used his authority to retaliate against a business owner for daring to speak out.

On March 19, 2025, Rino Ferrarese, CEO of Affinity Grow, testified before the General Law Committee against DCP’s rigid and costly “final form testing” policies. His exact words were:

“We’re basically the medical program operated with intermediate bulk testing from 2014 up until probably a couple months ago. So, we’re just continuing what we’ve been doing since 2014.”

Marriott seized on that single sentence, misheard it as an admission of non-compliance, and by the next morning had agents on their way to Ferrarese’s facility in Portland. Less than 24 hours after public testimony, Affinity Grow was targeted. No violations were found. But the message was unmistakable: challenge DCP, and you risk retaliation.

The Official Findings

The 13–page investigation by the Office of Labor Relations is damning. It documents how Marriott admitted to watching only part of Ferrarese’s testimony late at night, misheard the statement, and jumped to the conclusion that Affinity Grow was breaking the law. By the next morning, he had ordered an unannounced inspection.

The report concludes Marriott failed to exercise due diligence, acted on misinformation, and displayed “poor judgment” that was “detrimental to the best interests of the agency.” Even DCP Commissioner Bryan Cafferelli acknowledged the damage, warning that the action had destroyed trust with both the legislature and the cannabis industry .

The Fallout

Thanks to a WSHU Freedom of Information Act request, more than 100 internal documents have now come to light, including Teams messages where Marriott sheepishly admitted: “Uh oh, I think I messed up.”

The fallout forced public apologies from DCP leadership, who scrambled to assure lawmakers and licensees that testimony would not be punished. But the damage was already done. Marriott resigned on September 2, 2025, after 17 years at the agency, just one day after facing a pre-disciplinary hearing .

Full WSHU coverage:

https://www.wshu.org/connecticut-news/2025-09-16/ct-dcp-drug-director-named-in-unauthorized-cannabis-inspection

  • March 19, 2025 – Rino Ferrarese of Affinity Grow testifies before the General Law Committee, opposing DCP’s final form testing policy.
  • March 20, 2025 (Morning) – Rodrick Marriott misinterprets testimony and orders staff to inspect Affinity Grow.
  • March 20, 2025 (Afternoon) – DCP agents arrive at Affinity Grow, find no violations.
  • March 21, 2025 – Legislators publicly rebuke DCP, citing chilling effect on testimony.
  • March 24, 2025 – Formal labor investigation requested into Marriott’s actions.
  • March 27, 2025 – Investigation officially begins.
  • May 30, 2025 – Internal report released, concluding Marriott showed poor judgment and harmed public trust.
  • August 6, 2025 – Marriott faces pre-disciplinary hearing; a five-day suspension considered.
  • August 7, 2025 – Marriott resigns after 17 years at DCP.
  • September 2, 2025 – Marriott’s resignation becomes effective.
  • September 16, 2025 – WSHU publishes FOIA findings and confirms the scandal publicly.

Lawmakers’ Rebuke

During the March 21 follow-up meeting, General Law Committee co-chair Rep. Roland Lemar made clear how damaging Marriott’s decision was:

“We invited a number of people to give us expertise… One of the individuals testified in a way that could have been misconstrued or misheard, but it led to a subsequent action by the Department of Consumer Protection where he felt, and this committee feels, inadvertently or purposefully, his business was put in jeopardy. It is our goal as a committee to be a place where constituents feel welcome… without fear. I have an expectation that I can offer that space here. I failed to offer that space. This action was unacceptable.”

Those are extraordinary words: a sitting lawmaker admitting the state failed to protect the public’s right to speak freely.

A Pattern, Not a Fluke

DCP’s statement after Marriott’s resignation tried to downplay the scandal: “We do not anticipate any further issues of this nature.” That’s wishful thinking. For years, patients, caregivers, and advocates have complained of intimidation, selective enforcement, and a regulatory approach designed to protect corporate interests rather than empower small businesses or the public.

This inspection was not a “misheard” one-off. It was the logical outcome of a system where regulators believe they are untouchable, where cannabis businesses must tiptoe around the agency in fear of retaliation.

The Cost of Silence

If business owners believe that speaking at the Capitol could trigger a punitive inspection, democracy itself is undermined. Connecticut’s legalization law was sold on promises of equity and transparency — yet its implementation has been defined by secrecy, favoritism, and retaliation.

Where We Go From Here

Marriott may be gone, but the culture that enabled his misconduct remains. DCP must be stripped of its unilateral enforcement power over cannabis. Independent oversight is needed, and legislators must ensure that regulators cannot weaponize inspections against those who dissent.

Until that happens, the fear will remain. Entrepreneurs will stay silent. Patients will suffer. And DCP will continue to operate as if it is above accountability.

This scandal is not just about one man’s poor judgment — it is about an agency that has lost the trust of the very people it was meant to serve.

– WSHU Public Radio, “CT DCP drug director named in unauthorized cannabis inspection,” September 16, 2025 https://www.wshu.org/connecticut-news/2025-09-16/ct-dcp-drug-director-named-in-unauthorized-cannabis-inspection

Sources

  1. – Labor Relations Internal Investigation Summary, Office of Labor Relations, May 30, 2025

This story was originally published by Connecticut CannaTimes on Facebook on September 16, 2025 and was migrated to this website on October 16, 2026. The publication date above is the original date.